Cargando…

Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach

Hepatocellular carcinoma is becoming an increasing indication for liver transplantation, but selection and allocation of patients are challenging because of organ shortages. Conventional Milan criteria are the reference for the selection of patients worldwide, but many expanded criteria, like Univer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biolato, Marco, Marrone, Giuseppe, Miele, Luca, Gasbarrini, Antonio, Grieco, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434425/ https://www.ncbi.nlm.nih.gov/pubmed/28566879 http://dx.doi.org/10.3748/wjg.v23.i18.3195

Ejemplares similares

Upper Limits of Downstaging for Hepatocellular Carcinoma in Liver Transplantation
por: Biolato, Marco, et al.
Publicado: (2021)

Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation
por: Nicoletti, Alberto, et al.
Publicado: (2019)

Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties
por: Marrone, Giuseppe, et al.
Publicado: (2023)

Gallbladder perforation without cholecystitis in a patient awaiting liver transplantation: a peculiar case report of anaemia in cirrhosis
por: Biolato, Marco, et al.
Publicado: (2019)

Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia
por: Biolato, Marco, et al.
Publicado: (2022)

Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease
por: Biolato, Marco, et al.
Publicado: (2019)

A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series
por: Biolato, Marco, et al.
Publicado: (2022)

Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence?
por: Biolato, Marco, et al.
Publicado: (2022)

The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review
por: Biolato, Marco, et al.
Publicado: (2021)

Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma
por: Ponziani, Francesca Romana, et al.
Publicado: (2017)

The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease
por: Sanduzzi Zamparelli, Marco, et al.
Publicado: (2016)

Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI
por: Marrone, Giuseppe, et al.
Publicado: (2021)

Correction to: Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI
por: Marrone, Giuseppe, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy
por: Fianchi, Francesca, et al.
Publicado: (2021)

Minimum platelet count threshold before invasive procedures in cirrhosis: Evolution of the guidelines
por: Biolato, Marco, et al.
Publicado: (2023)

Effect of liver transplantation on intestinal permeability and correlation with infection episodes
por: Ponziani, Francesca Romana, et al.
Publicado: (2020)

A Role for the Biological Clock in Liver Cancer
por: Mazzoccoli, Gianluigi, et al.
Publicado: (2019)

Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients
por: Nociti, Viviana, et al.
Publicado: (2018)

Correlation of the transaminases alteration with the clinical severity of patients with COVID- 19: A meta-analysis of the first global outbreak
por: Miele, L., et al.
Publicado: (2021)

Disseminated intravascular coagulation after splenic artery aneurysm coils embolization: an unexpected surprise
por: Biolato, Marco, et al.
Publicado: (2023)

Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves
por: Miele, Luca, et al.
Publicado: (2023)

Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk
por: Miele, Luca, et al.
Publicado: (2015)

Artificial intelligence and big data processing for the development of predictive models to support Covid-19 hospital patients
por: Miele, L., et al.
Publicado: (2022)

The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma
por: Boccia, Stefania, et al.
Publicado: (2015)

The Histone Variant MacroH2A1 Impacts Circadian Gene Expression and Cell Phenotype in an In Vitro Model of Hepatocellular Carcinoma
por: Carbone, Annalucia, et al.
Publicado: (2021)

Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation
por: Kim, Bo Hyun, et al.
Publicado: (2018)

Imaging of hepatocellular carcinoma recurrence after liver transplantation
por: Mamone, Giuseppe, et al.
Publicado: (2023)

Can hepatocellular carcinoma recurrence be prevented after liver transplantation?
por: Kim, Jong Man
Publicado: (2021)

Is the Barcelona Clinic Liver Cancer guideline for treating intermediate to advanced staged hepatocellular carcinoma still appropriate?
por: Kang, Koo Jeong, et al.
Publicado: (2021)

Severe Cholestatic Hepatitis due to Temozolomide: An Adverse Drug Effect to Keep in Mind. Case Report and Review of Literature
por: Grieco, Antonio, et al.
Publicado: (2015)

Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma
por: Tsai, Ming Chao, et al.
Publicado: (2022)

Increasing Awareness on Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States
por: Frenette, Catherine T.
Publicado: (2019)

Growing need of adjuvant therapy and expanded access for liver transplant in hepatocellular carcinoma
por: Mukthinuthalapati, V. V. Pavan Kedar, et al.
Publicado: (2023)

Hepatocellular carcinoma in non-alcoholic fatty liver disease from a clinical and public health perspective
por: Díaz, Luis Antonio, et al.
Publicado: (2022)

Non‐alcoholic fatty liver disease and the risk of fibrosis in Italian primary care services: GPS‐NAFLD Study
por: Miele, Luca, et al.
Publicado: (2022)

Abdominal angina due to recurrence of cancer of the papilla of Vater: a case report
por: Biolato, Marco, et al.
Publicado: (2009)

Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD)
por: Buzova, Diana, et al.
Publicado: (2020)

Copper/MYC/CTR1 interplay: a dangerous relationship in hepatocellular carcinoma
por: Porcu, Cristiana, et al.
Publicado: (2018)

Bridging and downstaging with TACE in early and intermediate stage hepatocellular carcinoma: Predictors of receiving a liver transplant
por: Yin, Chao, et al.
Publicado: (2022)

Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: The Prognostic Role of Liver Stiffness Measurement
por: Cerrito, Lucia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d02v72m52tl3vpq5a5t5kjnkib